Researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery.

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...

SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human ...